Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May;15(3):279-280.
doi: 10.2450/2016.0156-16. Epub 2016 Jul 28.

The increased demand for plasma-derived factor VIII in Italy

Romano Arcieri  1 , Gabriele Calizzani  2 , Fabio Candura  2 , Pier Mannuccio Mannucci  3
Affiliations
Comment

The increased demand for plasma-derived factor VIII in Italy

Romano Arcieri et al. Blood Transfus. 2017 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Total demands for factor VIII per country in Europe, USA and Canada (2014).
Figure 2
Figure 2
National and regional total demands for plasma-derived and recombinant factor VIII in Italy (2014).
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Rocino A, Coppola A, Franchini M, et al. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. Blood Transfus. 2014;12:575–98. - PMC - PubMed
    1. Candura F, Lanzoni M, Calizzani G, et al. Rapporti ISTISAN 16/7. Roma: Istituto Superiore di Sanità; 2016. [In Italian.]
    1. Makris M. Prophylaxis in haemophilia should be life-long. Blood Transfus. 2012;10:165–8. - PMC - PubMed
    1. Mannucci PM, Mancuso ME, Santagostino E. How we choose factor VIII to treat hemophilia. Blood. 2012;119:4108–14. - PubMed
    1. Peyvandi F, Mannucci PM, Garagiola I, et al. Source of factor VIII replacement (plasmatic or recombinant) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the multicenter randomized SIPPET study. N Engl J Med. 2016;374:2054–64. - PubMed